Lexoraa Industries Ltd

Financial highlights

• Standalone total income from operations: ₹1,113.47 Lakhs in Q1 FY2026 vs ₹154.46 Lakhs in Q1 FY2025.
• Standalone net profit after tax: ₹-27.78 Lakhs in Q1 FY2026.
• Consolidated revenue: ₹1,113.47 Lakhs; consolidated net loss: ₹-27.78 Lakhs.
• EPS (basic and diluted) for continuing operations: ₹-0.71.
• Acquisition of Any and Every Exports Limited completed Apr 1, 2026; consolidation includes subsidiary.
• Company operates in one segment.
• Results reviewed by auditors; Limited Review submitted to BSE; Board approved on 25-07-2026.

Financial results approved

• Board approved unaudited standalone and consolidated results for quarter ended 30 June 2026.
• Limited Review Report on the unaudited results approved.
• Standalone revenue ₹1,113.47 lakh; net loss after tax ₹27.78 lakh; EPS -0.71.
• Consolidated revenue ₹1,113.47 lakh; net loss after tax ₹27.78 lakh; EPS -0.71.

Subsidiary acquisition and consolidation

• Parent acquired 100% stake in Any and Every Exports Limited effective 01-Apr-2026.
• Consolidated results include the subsidiary from 01-Apr-2026; comparatives not strictly comparable.
• Subsidiary had not commenced operations during quarter ended 30-Jun-2026.

Auditor/regulatory observations

• Audit Committee reviewed and recommended results; Board approved.
• Standalone results are subject to Limited Review; no auditor qualifications.
• Independent review of consolidation reports concluded no material misstatement.

Dematerialisation status

• Dematerialisation requests processed and confirmed to depositories; securities listed on exchanges.
• Physical certificates were mutilated and cancelled after verification.
• Depository name substituted as registered owner in the records within prescribed timelines.

Rights issue details

• Fully paid-up equity shares, face ₹10, premium ₹5 per share.
• Issue type: rights issue to existing equity shareholders.
• Aggregate size up to ₹69 crores; number of shares to be decided.
• Issue price: ₹15 per share (₹10 face value + ₹5 premium).
• Not a convertible instrument.
• Investors: existing equity shareholders.
• Listing status: not disclosed.
• Cancellation/termination: not disclosed.
• Impact on capital structure to be determined.

Rights issue approval

• Board approved fundraising up to ₹69 crore via rights issue to existing shareholders.
• Equity shares to have ₹10 face value and ₹5 premium per share.
• Rights issue offered to eligible existing shareholders as on record date.
• Record date to be determined and notified subsequently.
• Subject to applicable regulatory and statutory approvals.

Meeting Details

• Date: July 03, 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve various fund-raising options for the company.
• Consider and approve any other matter incidental and connected thereto.

Other Notes

• No additional notes disclosed.

Corporate Approvals

• Special Resolution to increase loan, investment, and guarantee limits by Rs. 1,000 crore beyond statutory caps.
• Ordinary Resolution to increase authorized share capital from Rs. 20 crore to Rs. 50 crore (5 crore shares of Rs. 10 each).
• Special Resolution to authorize borrowings up to Rs. 1,000 crore exceeding paid-up capital and free reserves.
• Special Resolution to create charges/mortgages on company assets up to Rs. 1,000 crore to secure borrowings.
• Special Resolution to approve loans, guarantees, or securities to subsidiaries/related persons under Sections 185 and 186.
• Special Resolution to approve related party transactions for purchase/sale of goods up to Rs. 1,000 crore for FY 2025-26 to 2029-30.

Shareholding and Interests

• No director or key managerial personnel has direct financial interest in resolutions except shareholding.

Strategic Impact

• Increase in authorized capital facilitates future equity or convertible securities issuance for fund raising.
• Borrowing and security approvals enable flexible financing for business operations and expansion.
• Related party transactions are at arm’s length and in ordinary course of business, recommended by Audit Committee.

Meeting and Voting Details ️

• EGM scheduled for 31 March 2026 via video conferencing; e-voting from 28 to 30 March 2026.
• Voting rights based on shareholding as of 24 March 2026 cut-off date.
• Physical attendance dispensed; shareholders to vote via remote e-voting or VC/OAVM platform.
• No proxy facility; corporate shareholders to authorize representatives for voting.

Governance Actions

• Board authorized to complete all filings and formalities to implement approved resolutions.